American Capital Advisory’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
American Capital Advisory's BMY Position: Q2 2026 in Review
American Capital Advisory increased its Bristol-Myers Squibb (BMY) stake by 0.71% in Q2 2026, buying an estimated $976 and bringing the position to 2,414 shares worth $139K. The position accounts for 0.05% of the portfolio, ranked #128.
American Capital Advisory first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $559K in Q1 2024. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- American Capital Advisory held 2,414 shares of Bristol-Myers Squibb worth $139K as of Q2 2026.
- American Capital Advisory bought 17 Bristol-Myers Squibb shares in Q2 2026, an estimated $976.
- Bristol-Myers Squibb made up 0.05% of American Capital Advisory's portfolio in Q2 2026, its #128 holding.
- American Capital Advisory first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
- American Capital Advisory's Bristol-Myers Squibb position peaked at $559K in Q1 2024.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.